ReviewPediatric blood & cancer2022

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.

Josephine H Haduong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.